Global Crohn’s Disease Therapeutics Market Size, Status and Forecast 2020-2026

May 2020 | 98 pages | ID: GC41DF1789B0EN
QYResearch

Abstracts

This report focuses on the global Crohn’s Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Crohn’s Disease Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Johnson and Johnson Services Inc.
• Pfizer Inc.
• Allergan
• AbbVie Inc.
• Takeda Pharmaceutical Company Limited
• Celgene Corporation
• Perrigo Company PLC
• Ferring B.V.
• Salix Pharmaceuticals
• Gilead Sciences Inc.
• Genentech Inc.
• UCB India Private Limited.

Market segment by Type, the product can be split into

• Non-Surgical
• Surgical

Market segment by Application, split into

• Hospitals
• Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Crohn’s Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the Crohn’s Disease Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Crohn’s Disease Therapeutics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Crohn’s Disease Therapeutics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Non-Surgical
  1.4.3 Surgical
1.5 Market by Application
  1.5.1 Global Crohn’s Disease Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals
  1.5.3 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Crohn’s Disease Therapeutics Market Perspective (2015-2026)
2.2 Crohn’s Disease Therapeutics Growth Trends by Regions
  2.2.1 Crohn’s Disease Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Crohn’s Disease Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 Crohn’s Disease Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Crohn’s Disease Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key Crohn’s Disease Therapeutics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Crohn’s Disease Therapeutics Players by Market Size
  3.1.1 Global Top Crohn’s Disease Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Crohn’s Disease Therapeutics Market Concentration Ratio
  3.2.1 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Therapeutics Revenue in 2019
3.3 Crohn’s Disease Therapeutics Key Players Head office and Area Served
3.4 Key Players Crohn’s Disease Therapeutics Product Solution and Service
3.5 Date of Enter into Crohn’s Disease Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Crohn’s Disease Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2021-2026)

5 CROHN’S DISEASE THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Crohn’s Disease Therapeutics Market Size by Application (2015-2020)
5.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Crohn’s Disease Therapeutics Market Size (2015-2020)
6.2 Crohn’s Disease Therapeutics Key Players in North America (2019-2020)
6.3 North America Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
6.4 North America Crohn’s Disease Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Crohn’s Disease Therapeutics Market Size (2015-2020)
7.2 Crohn’s Disease Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
7.4 Europe Crohn’s Disease Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China Crohn’s Disease Therapeutics Market Size (2015-2020)
8.2 Crohn’s Disease Therapeutics Key Players in China (2019-2020)
8.3 China Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
8.4 China Crohn’s Disease Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Crohn’s Disease Therapeutics Market Size (2015-2020)
9.2 Crohn’s Disease Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
9.4 Japan Crohn’s Disease Therapeutics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Crohn’s Disease Therapeutics Market Size (2015-2020)
10.2 Crohn’s Disease Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Crohn’s Disease Therapeutics Market Size by Application (2015-2020)

11 INDIA

11.1 India Crohn’s Disease Therapeutics Market Size (2015-2020)
11.2 Crohn’s Disease Therapeutics Key Players in India (2019-2020)
11.3 India Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
11.4 India Crohn’s Disease Therapeutics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Crohn’s Disease Therapeutics Market Size (2015-2020)
12.2 Crohn’s Disease Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Crohn’s Disease Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Crohn’s Disease Therapeutics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Johnson and Johnson Services Inc.
  13.1.1 Johnson and Johnson Services Inc. Company Details
  13.1.2 Johnson and Johnson Services Inc. Business Overview and Its Total Revenue
  13.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
  13.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020))
  13.1.5 Johnson and Johnson Services Inc. Recent Development
13.2 Pfizer Inc.
  13.2.1 Pfizer Inc. Company Details
  13.2.2 Pfizer Inc. Business Overview and Its Total Revenue
  13.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
  13.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.2.5 Pfizer Inc. Recent Development
13.3 Allergan
  13.3.1 Allergan Company Details
  13.3.2 Allergan Business Overview and Its Total Revenue
  13.3.3 Allergan Crohn’s Disease Therapeutics Introduction
  13.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.3.5 Allergan Recent Development
13.4 AbbVie Inc.
  13.4.1 AbbVie Inc. Company Details
  13.4.2 AbbVie Inc. Business Overview and Its Total Revenue
  13.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
  13.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.4.5 AbbVie Inc. Recent Development
13.5 Takeda Pharmaceutical Company Limited
  13.5.1 Takeda Pharmaceutical Company Limited Company Details
  13.5.2 Takeda Pharmaceutical Company Limited Business Overview and Its Total Revenue
  13.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
  13.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.5.5 Takeda Pharmaceutical Company Limited Recent Development
13.6 Celgene Corporation
  13.6.1 Celgene Corporation Company Details
  13.6.2 Celgene Corporation Business Overview and Its Total Revenue
  13.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
  13.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.6.5 Celgene Corporation Recent Development
13.7 Perrigo Company PLC
  13.7.1 Perrigo Company PLC Company Details
  13.7.2 Perrigo Company PLC Business Overview and Its Total Revenue
  13.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
  13.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.7.5 Perrigo Company PLC Recent Development
13.8 Ferring B.V.
  13.8.1 Ferring B.V. Company Details
  13.8.2 Ferring B.V. Business Overview and Its Total Revenue
  13.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
  13.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.8.5 Ferring B.V. Recent Development
13.9 Salix Pharmaceuticals
  13.9.1 Salix Pharmaceuticals Company Details
  13.9.2 Salix Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
  13.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.9.5 Salix Pharmaceuticals Recent Development
13.10 Gilead Sciences Inc.
  13.10.1 Gilead Sciences Inc. Company Details
  13.10.2 Gilead Sciences Inc. Business Overview and Its Total Revenue
  13.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
  13.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  13.10.5 Gilead Sciences Inc. Recent Development
13.11 Genentech Inc.
  10.11.1 Genentech Inc. Company Details
  10.11.2 Genentech Inc. Business Overview and Its Total Revenue
  10.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
  10.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  10.11.5 Genentech Inc. Recent Development
13.12 UCB India Private Limited.
  10.12.1 UCB India Private Limited. Company Details
  10.12.2 UCB India Private Limited. Business Overview and Its Total Revenue
  10.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
  10.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2015-2020)
  10.12.5 UCB India Private Limited. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Crohn’s Disease Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Crohn’s Disease Therapeutics Revenue
Table 3. Ranking of Global Top Crohn’s Disease Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Non-Surgical
Table 6. Key Players of Surgical
Table 7. Global Crohn’s Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Crohn’s Disease Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Crohn’s Disease Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Crohn’s Disease Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Crohn’s Disease Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Crohn’s Disease Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Crohn’s Disease Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Crohn’s Disease Therapeutics Players
Table 18. Global Crohn’s Disease Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Crohn’s Disease Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Therapeutics as of 2019)
Table 21. Global Crohn’s Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Crohn’s Disease Therapeutics Product Solution and Service
Table 24. Date of Enter into Crohn’s Disease Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Crohn’s Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Crohn’s Disease Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Crohn’s Disease Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Crohn’s Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Crohn’s Disease Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Crohn’s Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Crohn’s Disease Therapeutics Market Share (2019-2020)
Table 34. North America Crohn’s Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Crohn’s Disease Therapeutics Market Share by Type (2015-2020)
Table 36. North America Crohn’s Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Crohn’s Disease Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Crohn’s Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Crohn’s Disease Therapeutics Market Share (2019-2020)
Table 40. Europe Crohn’s Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Crohn’s Disease Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Crohn’s Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Crohn’s Disease Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Crohn’s Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Crohn’s Disease Therapeutics Market Share (2019-2020)
Table 46. China Crohn’s Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Crohn’s Disease Therapeutics Market Share by Type (2015-2020)
Table 48. China Crohn’s Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Crohn’s Disease Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Crohn’s Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Crohn’s Disease Therapeutics Market Share (2019-2020)
Table 52. Japan Crohn’s Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Crohn’s Disease Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Crohn’s Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Crohn’s Disease Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Crohn’s Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Crohn’s Disease Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Crohn’s Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Crohn’s Disease Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Crohn’s Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Crohn’s Disease Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Crohn’s Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Crohn’s Disease Therapeutics Market Share (2019-2020)
Table 64. India Crohn’s Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Crohn’s Disease Therapeutics Market Share by Type (2015-2020)
Table 66. India Crohn’s Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Crohn’s Disease Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Crohn’s Disease Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Crohn’s Disease Therapeutics Market Share (2019-2020)
Table 70. Central & South America Crohn’s Disease Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Crohn’s Disease Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Crohn’s Disease Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Crohn’s Disease Therapeutics Market Share by Application (2015-2020)
Table 74. Johnson and Johnson Services Inc. Company Details
Table 75. Johnson and Johnson Services Inc. Business Overview
Table 76. Johnson and Johnson Services Inc. Product
Table 77. Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 78. Johnson and Johnson Services Inc. Recent Development
Table 79. Pfizer Inc. Company Details
Table 80. Pfizer Inc. Business Overview
Table 81. Pfizer Inc. Product
Table 82. Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 83. Pfizer Inc. Recent Development
Table 84. Allergan Company Details
Table 85. Allergan Business Overview
Table 86. Allergan Product
Table 87. Allergan Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 88. Allergan Recent Development
Table 89. AbbVie Inc. Company Details
Table 90. AbbVie Inc. Business Overview
Table 91. AbbVie Inc. Product
Table 92. AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 93. AbbVie Inc. Recent Development
Table 94. Takeda Pharmaceutical Company Limited Company Details
Table 95. Takeda Pharmaceutical Company Limited Business Overview
Table 96. Takeda Pharmaceutical Company Limited Product
Table 97. Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 98. Takeda Pharmaceutical Company Limited Recent Development
Table 99. Celgene Corporation Company Details
Table 100. Celgene Corporation Business Overview
Table 101. Celgene Corporation Product
Table 102. Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 103. Celgene Corporation Recent Development
Table 104. Perrigo Company PLC Company Details
Table 105. Perrigo Company PLC Business Overview
Table 106. Perrigo Company PLC Product
Table 107. Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 108. Perrigo Company PLC Recent Development
Table 109. Ferring B.V. Business Overview
Table 110. Ferring B.V. Product
Table 111. Ferring B.V. Company Details
Table 112. Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 113. Ferring B.V. Recent Development
Table 114. Salix Pharmaceuticals Company Details
Table 115. Salix Pharmaceuticals Business Overview
Table 116. Salix Pharmaceuticals Product
Table 117. Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 118. Salix Pharmaceuticals Recent Development
Table 119. Gilead Sciences Inc. Company Details
Table 120. Gilead Sciences Inc. Business Overview
Table 121. Gilead Sciences Inc. Product
Table 122. Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 123. Gilead Sciences Inc. Recent Development
Table 124. Genentech Inc. Company Details
Table 125. Genentech Inc. Business Overview
Table 126. Genentech Inc. Product
Table 127. Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 128. Genentech Inc. Recent Development
Table 129. UCB India Private Limited. Company Details
Table 130. UCB India Private Limited. Business Overview
Table 131. UCB India Private Limited. Product
Table 132. UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2015-2020) (Million US$)
Table 133. UCB India Private Limited. Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Crohn’s Disease Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Non-Surgical Features
Figure 3. Surgical Features
Figure 4. Global Crohn’s Disease Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Crohn’s Disease Therapeutics Report Years Considered
Figure 8. Global Crohn’s Disease Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Crohn’s Disease Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Crohn’s Disease Therapeutics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Crohn’s Disease Therapeutics Market Share by Players in 2019
Figure 13. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crohn’s Disease Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Crohn’s Disease Therapeutics Revenue in 2019
Figure 15. North America Crohn’s Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Crohn’s Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Crohn’s Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Crohn’s Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Crohn’s Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Crohn’s Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Crohn’s Disease Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Johnson and Johnson Services Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Johnson and Johnson Services Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 24. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Pfizer Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 26. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Allergan Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 28. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. AbbVie Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 30. Takeda Pharmaceutical Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 32. Celgene Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Celgene Corporation Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 34. Perrigo Company PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Perrigo Company PLC Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 36. Ferring B.V. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Ferring B.V. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 38. Salix Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 40. Gilead Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Gilead Sciences Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 42. Genentech Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Genentech Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 44. UCB India Private Limited. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. UCB India Private Limited. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed